Your English writing platform
Free sign upSuggestions(5)
Exact(26)
No participants were withdrawn from the study because of adverse events with the exception of one individual who had a transient high elevation of ALT temporally related to immunization but thought likely to be due to ingestion of a drug with known liver toxicity.
Four individuals withdrew from the study because of adverse events.
There were no withdrawals from the study because of adverse events.
None of the patients withdrew from the study because of adverse reactions.
These 2 cases were withdrawn from the study because of adverse events.
No patient of Group A1 withdrew from the study because of adverse effects.
Similar(34)
No subjects dropped out of the study because of adverse effects of metyrapone.
Five patients (10.4%) discontinued the study because of adverse effects during escitalopram.
Two patients dropped out of the study because of adverse events.
Twenty subjects did not complete the study because of adverse events.
Adverse events, including anemia and peripheral neuropathy, were reported in 51.5% of subjects, and 34.8% of subjects discontinued the study because of adverse events [ 40].
More suggestions(16)
from the study because of thrombotic
from the study because of toxic
from the treatment because of adverse
from the study because of unqualified
from the study because of severe
from the study because of neurosurgical
from the study because of difficult
from the study because of progressive
from the study because of unintentional
from the study because of unsuccessful
from the study because of insufficient
from the study because of incomplete
from the study because of possible
from the analysis because of adverse
from the market because of adverse
from the study because of non-pulmonary
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.
Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com